Rationale: Rhabdomyosarcoma (RMS) has known as a highly malignant soft tissue sarcoma, representing 5% to 10% of all solid tumors in childhood. Alveolar rhabdomyosarcoma (ARMS) of the retrorectal-presacral space is an extremely rare lesion for adult, no study has been reported in the English literature.
Introduction
Rhabdomyosarcoma (RMS), a rare malignancy originating from striated muscle tissue or primitive mesenchymal tissue, is typically observed in childhood and adolescence. Only a very small portion of RMS cases have been reported to develop in the adult population older than 20 years. [1] Adult RMS accounts for only 1% to 3% of all malignant soft tissue tumors. [2] The head and neck are the most frequent sites of origin, followed by the genitourinary tract, extremities, trunk, retroperitoneum, and uncommon regions. [3] [4] [5] [6] [7] [8] One of the least common sites for RMS is the retrorectal-presacral space. We present the case of a 51-year-old male with primary alveolar rhabdomyosarcoma (ARMS) of the retrorectal-presacral space, and to our knowledge, it is the first reported case of an ARMS developed in this location. Rarity of this disease and unusual presentation prompted us to report this case.
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Case description
A 51-year-old male presented with abdominal pain for 1 month, significantly worse when having a bowel movement. Therefore, he was admitted to our hospital. There were neither important risk factors such as family history nor an important history of medical/surgical treatment. Physical examination revealed an abdominal mass below the level of the umbilicus. No fever or history of weight loss was reported by the patient. Laboratory data, including blood test, chemistry, and tumor markers, were within normal limits.
Computed tomography (CT) of the abdomen showed a sharply defined solid-cystic mass (87Â93Â98 mm in size) with irregular density in retrorectal-presacral space, pushing and compressing the adjacent rectum (Fig. 1) . Magnetic resonance imaging (MRI) of the pelvis demonstrated a sharply defined solid-cystic mass containing irregular intensities. T1-weighted images revealed isointense and low-signal intensity, T2-weighted images revealed multiple cystic lesions of varying sizes of high-signal intensity, the solid components, and septums display intense but inhomogeneous enhancement on contrast-enhanced T1-weighted imaging (Fig. 2) .
Then, the patient underwent tumor resection. Surgery revealed a mass (95x100 mm), with soft texture, which was located at the retrorectal-presacral space. The surgical specimen was reported as ARMS after pathological evaluation. Microscopically, neoplastic cells had large, pleomorphic nuclei with considerable pleomorphism. Bizarre multinucleated giant cells with abundant eosinophilic cytoplasms were also present (Fig. 3A) . Immunohistochemical evaluations revealed positive staining for CD99, vimentin, CD34, and Desmin (Fig. 3B) . The staging of this patient was stage-I according to the American Intergroup Rhabdomyosarcoma Study (IRS). After surgery, the patient was treated with combination chemotherapy. Vinorelbine, ifosfamide, and actinomycin D were administered intravenously. At 23 months follow up, the patient was asymptomatic with no evidence of metastases or local recurrence. He underwent a metastatic workup that included a thoracic and abdominal CT scan with and without contrast enhancement and a total body bone scan. These results were negative for tumor.
Discussion
RMS is the most common sarcoma in the pediatric population, and it is very uncommon in adults, [2] it is thought to arise from immature mesenchymal cells that are committed to skeletal muscle lineage, but these tumors are also known to arise in tissues in which striated muscle is not normally found. RMS is classified into 4 major subtypes, embryonal RMS (ERMS), alveolar RMS (ARMS), pleomorphic RMS (PRMS) and spindle cell/sclerosing RMS (SRMS). [9] ARMS is most commonly seen in older children and young adults. [10] RMS can occur at various sites in the body, such as the head, neck, trunk, and extremities, including sites lacking normal striated muscle cells. The most common primary site in adults is the extremities, and the head and neck parameningeal region is the most common site in children. [11] Available data on the extremely infrequent localisations of adulthood, such as larynx, [12] renal pelvis, [13] subcutaneous tissue, [8] uterine, [14] retroperitoneal space, [7] and so on, are insufficient and scarce, mostly presented as case reports or single institution experiences with small numbers of patients. In fact, our patient is the first single-case report of ARMS arising from the retrorectal-presacral space in an adult male, within our thorough investigation.
Imaging findings of RMS are nonspecific. [6] The tumors may appear isointense and low signal intensity to surrounding skeletal muscle on T1-weighted MRI, high and heterogeneous signal on T2-weighted images and contrast-enhanced to variable degrees on T1-weighted sequences. [15, 16] Alveolar subtypes, in particular, may show areas of hemorrhage and necrosis as well. [17] But, in the case presented here, CT of the abdomen showed a sharply defined solidcystic mass with irregular density in retrorectal-presacral space. MRI of the pelvis demonstrated a well-defined solid-cystic enhancing mass. T1-weighted images revealed isointense and low-signal intensity, T2-weighted images revealed multiple cystic lesions of varying sizes of high-signal intensity, the solid components, and septums display intense but inhomogeneous enhancement on contrast-enhanced T1-weighted imaging. On imaging, the multiple cystic lesions of tumor on T2-weighted imaging with high-signal intensity is thought to be due to the necrosis.
There are multimodality treatment options for adult RMS, including surgery, radiation therapy for control of residual bulk or microscopic tumor and systemic combination chemotherapy for primary cytoreduction and eradication of gross and micrometastases. [18] Complete surgical resection is the mainstay of curative therapy to ablate the disease for early tumor stage in the absence of distant metastases. All patients with RMS must receive combination chemotherapy as soon as diagnosis is made or after resection. It improves survival significantly. RMS generally has a dismal prognosis, which has been described in most reports. The best prognostic factors are stage I with small size, less than 5 cm, absence of nodal involvement, and young age, less than 10 years. [19] The 51-year-old male patient in our case underwent tumor resection and received combination chemotherapy and achieved a satisfactory outcome, and so far he is being followed up.
Conclusions
In conclusion, this case has reminded us that ARMS could occur in uncommon site and older male. All radiologists should be aware its imaging features. Improvements in imaging in addition to early surgical intervention and chemotherapy treatment are crucial to improve survival chances. An accumulation of such cases is needed for further evaluation and research.
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